Description

Nilotinib is a modern and highly effective targeted therapy used in the treatment of certain types of blood cancer. It belongs to the class of Tyrosine Kinase Inhibitors (TKIs), which work by blocking abnormal signals responsible for uncontrolled cancer cell growth. NILOTHERAPY 150 (Nilotinib 150mg) by Steris Healthcare Pvt. Ltd. is specially formulated to manage Chronic Myeloid Leukemia (CML), a condition caused by the BCR-ABL gene mutation. This medicine is strictly prescription-based and should be taken only under the supervision of a qualified oncologist. Its targeted mechanism makes it a preferred choice in modern cancer therapy, offering improved disease control with better precision compared to traditional chemotherapy. Uses Nilotinib is primarily used for: Treatment of Chronic Myeloid Leukemia (CML) in adults Philadelphia chromosome-positive (Ph+) CML in chronic phase Accelerated phase CML Patients who are resistant or intolerant to first-line therapy such as Imatinib This medicine works by inhibiting the BCR-ABL tyrosine kinase protein, which is responsible for abnormal white blood cell production in CML patients. By blocking this protein, it helps slow or stop the progression of cancer. Benefits NILOTHERAPY 150 (Nilotinib 150mg) offers several important benefits when used under medical supervision: Targeted Action: Directly acts on cancer-causing proteins, reducing damage to healthy cells Better Disease Control: Helps in managing CML more effectively and reducing disease progression Effective in Resistant Cases: Works well in patients who do not respond to earlier treatments Oral Convenience: Easy-to-take tablet form improves patient adherence Long-Term Management: Supports long-term control of chronic myeloid leukemia These advantages make it an important therapy option in oncology treatment protocols. Dosage The dosage of Nilotinib is determined by the doctor based on the patient’s condition and response to treatment. General Guidelines: Usually taken twice daily as prescribed Must be taken on an empty stomach (2 hours after food and 1 hour before next meal) Tablets should be swallowed whole with water; do not crush or chew Important Instructions: Maintain a fixed dosing schedule Avoid grapefruit and grapefruit juice Do not double dose if one is missed Proper adherence is essential for effective results and safety. Side Effects Like all medicines, NILOTHERAPY 150 may cause side effects in some patients. Common Side Effects: Nausea Fatigue Headache Skin rash Muscle pain Constipation or diarrhea Serious Side Effects: Irregular heartbeat (QT prolongation) Liver function abnormalities Severe allergic reactions Unusual bleeding or bruising Pancreatitis Regular medical monitoring helps in early detection and management of these effects. Precautions and Warnings Before using Nilotinib, certain precautions should be followed: Patients with heart conditions should inform their doctor Regular ECG and blood tests are necessary during treatment Blood sugar levels may increase, especially in diabetic patients Liver function should be monitored regularly Avoid use during pregnancy and breastfeeding unless advised by a doctor Inform your doctor about all other medications to avoid interactions Strict adherence to medical supervision ensures safe and effective therapy. Conclusion NILOTHERAPY 150 (Nilotinib 150mg) is a highly advanced targeted therapy used in the management of Chronic Myeloid Leukemia. By specifically inhibiting the BCR-ABL protein, it helps control abnormal cell growth and improves long-term disease outcomes. With its precision-based action, oral convenience, and effectiveness in resistant cases, it plays a vital role in modern oncology treatment. However, it must always be used under strict medical guidance with regular monitoring to ensure safety and best results. Steris Healthcare Pvt. Ltd. continues to provide trusted oncology solutions like NILOTHERAPY 150, supporting patients in their journey toward better health management.